A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).Jochen H. Lorch, David A. Barbie, Roy B. Tishler et al.|Journal of Clinical Oncology|2020Cited by 65
Everolimus in Anaplastic Thyroid Cancer: A Case SeriesEthan Harris, Jochen H. Lorch, Glenn J. Hanna et al.|Frontiers in Oncology|2019Cited by 41
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec Kacew, Glenn J. Hanna, Ethan Harris et al.|European Journal of Cancer|2019Cited by 33
Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neckAlec Kacew, Glenn J. Hanna, Ethan Harris et al.|Oral Oncology|2020Cited by 30